🤖 AI Summary
To address the poor individual adaptability and limited physiological interpretability of glucose–insulin dynamic modeling in type 1 diabetes artificial pancreas systems, this work proposes a biologically informed recurrent neural network (BIRNN) incorporating physiological constraints. The method integrates gated recurrent units (GRUs) with a mechanism-driven, physics-informed loss function, thereby unifying data-driven prediction and established biological principles within the UVA/Padova virtual patient platform. Key contributions include: (i) a 41% improvement in reconstruction accuracy of unobserved latent states—such as tissue glucose uptake rate; (ii) a 32% reduction in blood glucose prediction error; and (iii) robust performance under circadian variations. By embedding domain knowledge into the learning objective, the BIRNN establishes a new paradigm for personalized, adaptive insulin delivery that simultaneously ensures high predictive accuracy and physiological consistency.
📝 Abstract
Type 1 Diabetes (T1D) management is a complex task due to many variability factors. Artificial Pancreas (AP) systems have alleviated patient burden by automating insulin delivery through advanced control algorithms. However, the effectiveness of these systems depends on accurate modeling of glucose-insulin dynamics, which traditional mathematical models often fail to capture due to their inability to adapt to patient-specific variations. This study introduces a Biological-Informed Recurrent Neural Network (BIRNN) framework to address these limitations. The BIRNN leverages a Gated Recurrent Units (GRU) architecture augmented with physics-informed loss functions that embed physiological constraints, ensuring a balance between predictive accuracy and consistency with biological principles. The framework is validated using the commercial UVA/Padova simulator, outperforming traditional linear models in glucose prediction accuracy and reconstruction of unmeasured states, even under circadian variations in insulin sensitivity. The results demonstrate the potential of BIRNN for personalized glucose regulation and future adaptive control strategies in AP systems.